RxDoctor Payments DataLook up a doctor →

Michael Cassell, MD

Retina Specialist · Kansas City, MONPI 1932107000

Payments from drug & device makers

$389,067in general payments, 2019–2025

Across 105 payments — averaging $3705.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$379K
  • Apellis Pharmaceuticals, Inc.$5K
  • ANI Pharmaceuticals, Inc.$3K
  • Alcon$1K
  • Genentech USA, Inc.$366
  • Sun Pharmaceutical Industries Inc.$202
  • plus $758 from 13 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$389,067 in reported general payments places this provider in the 90th percentile of 45 retina specialist providers in Missouri.

See all retina specialist providers in Missouri

Medicare billing

Part B allowed, 2024
$2,180,277
Medicare patients
1,210
Services billed
15,221

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other retina specialist in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →